Thierry Dervieux, PharmD, PhD, Chief Scientific Officer, was most recently Chief Scientific Officer at Exagen Diagnostics, where he spent a decade building the Avise® portfolio of testing solutions. Prior to Exagen, Thierry was a founding executive of Proprius Pharmaceuticals (sold to Cypress Biosciences), where he started to develop a portfolio of precision guided dosing solutions for the management of AI gastrointestinal and rheumatic diseases. He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Molecular Diagnostics and holds PharmD and PhD degrees from Claude Bernard University. Thierry is the inventor or co-inventor on several patents and patent applications and has authored or co-authored over 70 publications.